Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 80-90

  Yin, Yiming ^a   Choi, Seung Chul ^a   Xu, Zhiwei ^a   Zeumer, Leilani ^a   Kanda, Nathalie ^a   Croker, Byron P ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; DICHLOROACETIC ACID; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 17; LACTIC ACID; METFORMIN; PYRUVIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GLUCOSE OXIDATION; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; ENERGY METABOLISM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DEOXYGLUCOSE; DICHLOROACETIC ACID; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUCOSE; INTERFERON-GAMMA; INTERLEUKIN-17; LACTIC ACID; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; METFORMIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PYRUVIC ACID;

EID: 84953335448     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501537     Document Type: Article

References (46)

1. Moulton, V. R., and G. C. Tsokos. 2015. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J. Clin. Invest. 125: 2220-2227.
2. Ohl, K., and K. Tenbrock. 2015. Regulatory T cells in systemic lupus erythematosus. Eur. J. Immunol. 45: 344-355.
3. Crispin, J. C, and G. C. Tsokos. 2010. Interleukin-17-producing T cells in lupus. Curr. Opin. Rheumatol. 22: 499-503.
4. Pollard, K. M., D. M. Cauvi, C. B. Toomey, K. V. Morris, and D. H. Kono. 2013. Interferon-7 and systemic autoimmunity. Discov. Med. 16: 123-131.
5. Richards, H. B., M. Satoh, J. C. Jennette, B. P. Croker, H. Yoshida, and W. H. Reeves. 2001. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 60: 2173-2180.
6. Haas, C, B. Ryffel, and M. Le Hir. 1998. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW) Fl mice. J. Immunol. 160: 3713-3718.
7. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99: 1936-1946.
8. Zhang, Z., V. C. Kyttaris, and G. C. Tsokos. 2009. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 183: 3160-3169.
9. Amarilyo, G., E. V. Lourengo, F.-D. Shi, and A. La Cava. 2014. IL-17 promotes murine lupus. J. Immunol. 193: 540-543.
10. Comte, D., M. P. Karampetsou, and G. C. Tsokos. 2015. T cells as a therapeutic target in SLE. Lupus 24: 351-363.
11. Maclver, N. J., R. D. Michalek, and J. C. Rathmell. 2013. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31: 259-283.
12. Bricker, D. K., E. B. Taylor, J. C. Schell, T. Orsak, A. Boutron, Y. C. Chen, J. E. Cox, C. M. Cardon, J. G. Van Vranken, N. Dephoure, et al. 2012. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337: 96-100.
13. Herzig, S., E. Raemy, S. Montessuit, J. L. Veuthey, N. Zamboni, B. Westermann, E. R. Kunji, and J. C. Martinou. 2012. Identification and functional expression of the mitochondrial pyruvate carrier. Science 337: 93-96.
14. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
15. Wang, R., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
16. Berod, L., C. Friedrich, A. Nandan, J. Freitag, S. Hagemann, K. Harmrolfs, A. Sandouk, C. Hesse, C. N. Castro, H. Bahre, et al. 2014. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20: 1327-1333.
17. Michalek, R. D., V. A. Gerriets, A. G. Nichols, M. Inoue, D. Kazmin, C. Y. Chang, M. A. Dwyer, E. R. Nelson, K. N. Pollizzi, O. Ilkayeva, et al. 2011. Estrogen-related receptor-a is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl. Acad. Sci. USA 108: 18348-18353.
18. Sena, L. A., S. Li, A. Jairaman, M. Prakriya, T. Ezponda, D. A. Hildeman, C. R. Wang, P. T. Schumacker, J. D. Licht, H. Perlman, et al. 2013. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38: 225-236.
19. + T cell metabolism reverses lupus. Sci. Transl. Med. 7: 274ral8.
20. He, L., and F. E. Wondisford. 2015. Metformin action: concentrations matter. Cell Metab. 21: 159-162.
21. Mehta, M. M., and N. S. Chandel. 2015. Targeting metabolism for lupus therapy. Sci. Transl. Med. 7: 274fs5.
22. Perl, A, P. Gergely, Jr., G. Nagy, A. Koncz, and K. Banki. 2004. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25: 360-367.
23. Wahl, D. R., B. Petersen, R. Warner, B. C. Richardson, G. D. Glick, and A. W. Opipari. 2010. Characterization of the metabolic phenotype of chronically activated lymphocytes. Lupus 19: 1492-1501.
24. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675.
25. Xu, Z., C. M. Cuda, B. P. Croker, and L. Morel. 2011. The NZM2410-derived lupus susceptibility locus Sle2cl increases Thl7 polarization and induces nephritis in fas-deficient mice. Arthritis Rheum. 63: 764-774.
26. + T cell subsets and inflammation. J. Clin. Invest. 125: 194-207.
27. Kaplon, J., L. Zheng, K. Meissl, B. Chaneton, V. A. Selivanov, G. Mackay, S. H. van der Burg, E. M. Verdegaal, M. Cascante, T. Shlomi, et al. 2013. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498: 109-112.
28. Michelakis, E. D., G. Sutendra, P. Dromparis, L. Webster, A. Haromy, E. Niven, C. Maguire, T. L. Gammer, J. R. Mackey, D. Fulton, et al. 2010. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med. 2: 31ra34.
29. Zhao, W., C. C. Berthier, E. E. Lewis, W. J. McCune, M. Kretzler, and M. J. Kaplan. 2013. The peroxisome-proliferator activated receptor-7 agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus. Clin. Immunol. 149: 119-132.
30. Aprahamian, T, R. G. Bonegio, C. Richez, K. Yasuda, L.-K. Chiang, K. Sato, K. Walsh, and I. R. Rifkin. 2009. The peroxisome proliferator-activated receptor 7 agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J. Immunol. 182: 340-346.
31. Divakaruni, A. S., S. E. Wiley, G. W. Rogers, A. Y. Andreyev, S. Petrosyan, M. Loviscach, E. A. Wall, N. Yadava, A. P. Heuck, D. A. Ferrick, et al. 2013. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc. Natl. Acad. Sci. USA 110: 5422-5427.
32. Colca, J. R., W. G. McDonald, G. S. Cavey, S. L. Cole, D. D. Holewa, A. S. Brightwell-Conrad, C. L. Wolfe, J. S. Wheeler, K. R. Coulter, P. M. Kilkuskie, et al. 2013. Identification of a mitochondrial target of thiazo-lidinedione insulin sensitizers (mTOT)-relationship to newly identified mitochondrial pyruvate carrier proteins. PLoS One 8: e61551.
33. Kyttaris, V. C, Z. Zhang, V. K. Kuchroo, M. Oukka, and G. C. Tsokos. 2010. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J. Immunol. 184: 4605-4609.
34. + T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39: 770-781.
35. Choi, J. Y, J. H. Ho, S. G. Pasoto, V. Bunin, S. T. Kim, S. Carrasco, E. F. Borba, C. R. Goncalves, P. R. Costa, E. G. Kallas, et al. 2015. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 67: 988-999.
36. Ray, J. P., M. M. Staron, J. A. Shyer, P. C. Ho, H. D. Marshall, S. M. Gray, B. J. Laidlaw, K. Araki, R. Ahmed, S. M. Kaech, and J. Craft. The interleukin-2-mTORc 1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43: 690-702.
37. Pearce, E. L., and E. J. Pearce. 2013. Metabolic pathways in immune cell activation and quiescence. Immunity 38: 633-643.
38. Weinberg, S. E., L. A. Sena, and N. S. Chandel. 2015. Mitochondria in the regulation of innate and adaptive immunity. Immunity 42: 406-417.
39. Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. van der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.
40. Pearce, E. L., M. C. Poffenberger, C. H. Chang, and R. G. Jones. 2013. Fueling immunity: insights into metabolism and lymphocyte function. Science 342: 1242454.
41. Glick, G. D., R. Rossignol, C. A. Lyssiotis, D. Wahl, C. Lesch, B. Sanchez, X. Liu, L.-Y. Hao, C. Taylor, A. Hurd, et al. 2014. Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. J. Pharmacol. Exp. Ther. 351: 298-307.
42. Pagani, M., M. Rockstroh, M. Schuster, G. Rossetti, M. Moro, M. Crosti, and J. M. Tomm. 2015. Reference proteome of highly purified human Thl cells reveals strong effects on metabolism and protein ubiquitination upon differentiation. Proteomics 15: 3644-3647 .
43. Bubier, J. A., T. J. Sproule, O. Foreman, R. Spolski, D. J. Shaffer, H. C. Morse, III, W. J. Leonard, and D. C. Roopenian. 2009. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. USA 106: 1518-1523.
44. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. ATlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad Sci. USA 103: 9970-9975.
45. Moisini, I., W. Huang, R. Bethunaickan, R. Sahu, P. G. Ricketts, M. Akerman, T. Marion, M. Lesser, and A. Davidson. 2012. The Yaa locus and IFN-α fine-tune germinal center B cell selection in murine systemic lupus erythematosus. J. Immunol. 189: 4305-4312.
46. Gatza, E., D. R. Wahl, A. W. Opipari, T. B. Sundberg, P. Reddy, C. Liu, G. D. Glick, and J. L. M. Ferrara. 2011. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci. Transl. Med. 3: 67ra68. doi:10.1126/scitranslmed.3001975